Home Medicine Pathophysiological and Clinical Relevance of Circulating Levels of Cardiac Natriuretic Hormones: Are They Merely Markers of Cardiac Disease?
Article
Licensed
Unlicensed Requires Authentication

Pathophysiological and Clinical Relevance of Circulating Levels of Cardiac Natriuretic Hormones: Are They Merely Markers of Cardiac Disease?

  • Aldo Clerico
Published/Copyright: June 1, 2005
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 40 Issue 8

Abstract

Several specific and sensitive markers for myocardial injury as well as diagnostic tests for the assessment and stratification of cardiovascular risk have been recently introduced in clinical laboratories. However, until a few years ago, there were no laboratory tests for diagnosis, stratification and follow-up of patients with heart failure. The assay for cardiac natriuretic hormones (CNH) fills this gap. Heart failure is not only the most frequent “final common pathway” in cardiovascular disease, but is also the most common primary hospital discharge diagnosis, as well as the most common cause of death in patients over 50 years of age in Western countries; therefore, CNH assay may be destined to assume a growing relevance in clinical cardiology. However, to consider CNH assay only as a general and functional indicator of cardiac structural disease, without recalling that atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are powerful hormones, may lead to underestimation of the physiological role they play in healthy subjects as well as in patients with heart failure. Indeed, the circulating levels of CNH should be always interpreted taking into account not only hemodynamic factors and myocardial performance, but also their relationship with the counter-regulatory neuroendocrine system (including renin-angiotensin-aldosterone system, sympathetic system, endothelins, cytokines and vasopressin), as well as other hormones (such as sex steroid hormones, thyroid hormones and glucocorticoids).

:
Published Online: 2005-06-01
Published in Print: 2002-08-26

Copyright © 2002 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. SIBioC 2002 - 34th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, Rimini, Italy, 17-20 September 2002
  2. Santorini Biologie Prospective Conference 2002 From Genetic Variations to Risk Prediction and Pharmacogenomics Santorini, Greece, 25-28 September 2002
  3. CCLM Special Issue on Diabetes Mellitus - Call for Papers
  4. Pathophysiological and Clinical Relevance of Circulating Levels of Cardiac Natriuretic Hormones: Are They Merely Markers of Cardiac Disease?
  5. Comparative Measurement of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide in Ambulatory Patients with Heart Failure
  6. Tumor Necrosis Factor-α-Induced Accumulation of Tumor Suppressor Protein p53 and Cyclin-dependent Protein Kinase Inhibitory Protein p21 Is Inhibited by Insulin in ME-180S Cells
  7. Inflammatory Response to Coronary Stent Implantation in Patients with Unstable Angina
  8. Immature Granulocyte Count after Liver Transplantation
  9. An Ideal Substrate for the Measurement of Pancreatic Amylase?
  10. Defining the Period of Recovery of the Glucose Concentration after Its Local Perturbation by the Implantation of a Miniature Sensor
  11. Measurement of Serum β-Crosslaps Is Influenced by Proteolytic Conditions
  12. Quantitative Determination of Faecal Fatty Acids and Triglycerides by Fourier Transform Infrared Analysis with a Sodium Chloride Transmission Flow Cell
  13. Rapid Identification of Atypical Variant of Plasma Butyrylcholinesterase by PCR
  14. Determination of Nitrite Plus Nitrate and Malondialdehyde in Human Plasma: Analytical Performance and the Effect of Smoking and Exercise
  15. Iron Status in Black Persons Is Not Influenced by Haptoglobin Polymorphism
  16. Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency in the Eastern Province of Saudi Arabia
  17. Comparison of Urine Cell Characteristics by Flow Cytometry and Cytology in Patients Suspected of Having Bladder Cancer
  18. Clinical Validation of a Fully Automated 17β-Estradiol and Progesterone Assay (VIDAS®) for Use in Monitoring Assisted Reproduction Treatment
  19. Evaluation of a Commercially Available Serologic Assay for Antibodies against Tuberculosis-associated Glycolipid Antigen
  20. Evaluation of Two Modified Cardiac Troponin I Enzyme Immunoassays
  21. Evaluation of Denka-Seiken Turbidimetric High-Sensitivity C-Reactive Protein Assay
  22. Amiodarone and Desethylamiodarone Bind to Barrier Gels in Serum Separator Blood Collection Tubes
  23. A Novel Explanation for Low Alanine Aminotransferase Activity in Human Serum Caused by IgG Inhibitor
  24. Serum Total Antioxidant Status Is Higher in Postmenopausal Women and after Estrogen Replacement Therapy
  25. Immunoturbidimetric Assay for Serum Cystatin C Using the Cobas Fara Analyzer
  26. Meetings and Awards
Downloaded on 8.2.2026 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2002.129/html
Scroll to top button